ZA200908851B - Novel dicarboxylic acid derivatives as S1P1 receptor agonists - Google Patents
Novel dicarboxylic acid derivatives as S1P1 receptor agonistsInfo
- Publication number
- ZA200908851B ZA200908851B ZA200908851A ZA200908851A ZA200908851B ZA 200908851 B ZA200908851 B ZA 200908851B ZA 200908851 A ZA200908851 A ZA 200908851A ZA 200908851 A ZA200908851 A ZA 200908851A ZA 200908851 B ZA200908851 B ZA 200908851B
- Authority
- ZA
- South Africa
- Prior art keywords
- dicarboxylic acid
- acid derivatives
- receptor agonists
- novel dicarboxylic
- novel
- Prior art date
Links
- 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 title 1
- 108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 title 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 title 1
- 239000000018 receptor agonist Substances 0.000 title 1
- 229940044601 receptor agonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07290748A EP2014653A1 (fr) | 2007-06-15 | 2007-06-15 | Nouveaux dérivés d'acide dicarboxylique comme agonistes du recepteur S1P1 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200908851B true ZA200908851B (en) | 2010-07-28 |
Family
ID=38645817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200908851A ZA200908851B (en) | 2007-06-15 | 2009-12-11 | Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
Country Status (17)
Country | Link |
---|---|
US (1) | US8809539B2 (fr) |
EP (2) | EP2014653A1 (fr) |
JP (1) | JP5346016B2 (fr) |
KR (1) | KR20100040853A (fr) |
CN (1) | CN101784535A (fr) |
BR (1) | BRPI0811712A2 (fr) |
CA (1) | CA2693126A1 (fr) |
CO (1) | CO6251262A2 (fr) |
EA (1) | EA018826B1 (fr) |
IL (1) | IL202741A0 (fr) |
MA (1) | MA31447B1 (fr) |
MX (1) | MX2009013733A (fr) |
NZ (1) | NZ581933A (fr) |
TN (1) | TN2009000524A1 (fr) |
UA (1) | UA99132C2 (fr) |
WO (1) | WO2008152149A1 (fr) |
ZA (1) | ZA200908851B (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2193126B1 (fr) | 2007-10-04 | 2015-06-24 | Merck Serono S.A. | Composés d'oxadiazole diaryle |
US8202865B2 (en) * | 2007-10-04 | 2012-06-19 | Merck Serono Sa | Oxadiazole derivatives |
EP2209771A1 (fr) * | 2007-11-08 | 2010-07-28 | Pfizer, Inc. | Dérivés d'acide cyclobutylcarboxylique |
HUE030424T2 (en) | 2008-07-23 | 2017-05-29 | Arena Pharm Inc | Substituted 1,2,3,4-tetrahydrocyclopenta [b] indol-3-ylacetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
BRPI0917923B1 (pt) | 2008-08-27 | 2022-04-05 | Arena Pharmaceuticals Inc | Derivado de ácido tricíclico substituído, sua composição, seu uso e processo para preparar a referida composição |
EP2344446A4 (fr) | 2008-10-17 | 2012-04-04 | Akaal Pharma Pty Ltd | Modulateurs des récepteurs s1p |
NZ592748A (en) | 2008-10-17 | 2013-01-25 | Akaal Pharma Pty Ltd | 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators |
EP2241558A1 (fr) * | 2009-04-03 | 2010-10-20 | Merck Serono SA | Dérivés d'oxadiazole |
WO2011048409A1 (fr) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Dérivés d'amine cyclique ayant une activité agoniste de récepteur adrénergique bêta-2 et antagoniste de récepteur muscarinique |
EP3378854B1 (fr) | 2010-01-27 | 2022-12-21 | Arena Pharmaceuticals, Inc. | Procédés de préparation d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclopenta[b]indol-3-yl) acétique et de ses sels |
JP2013521301A (ja) | 2010-03-03 | 2013-06-10 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1p1受容体修飾物質およびその結晶形の調製のためのプロセス |
CN103119038B (zh) * | 2010-04-23 | 2016-05-04 | 百时美施贵宝公司 | 作为1-磷酸鞘氨醇1受体激动剂的4-(5-异噁唑基或5-吡唑基-1,2,4-噁二唑基-3-基)扁桃酰胺 |
CA2797668A1 (fr) | 2010-04-27 | 2011-11-03 | Allergan, Inc. | Derives de 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole en tant que modulateurs de recepteurs de sphingosine-1-phosphate |
US9050334B2 (en) | 2010-07-16 | 2015-06-09 | Innov88 Llc | MIF inhibitors and their uses |
ES2539256T3 (es) | 2010-07-20 | 2015-06-29 | Bristol-Myers Squibb Company | Compuestos de 3-fenil-1,2,4-oxadiazol sustituidos |
WO2012112841A2 (fr) * | 2011-02-18 | 2012-08-23 | Abbott Laboratories | Préparation de sels d'acide [1,2,4]oxadiazol-3-yl]-ylique et formes cristallines et leur préparation |
EP2511275A1 (fr) * | 2011-04-12 | 2012-10-17 | Bioprojet | Nouveaux acides pipéridiniles monocarboxyliques comme agonistes du récepteur S1P1 |
MX2021011472A (es) | 2015-01-06 | 2022-08-17 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
KR102603199B1 (ko) | 2015-06-22 | 2023-11-16 | 아레나 파마슈티칼스, 인크. | S1p1 수용체-관련 장애에서의 사용을 위한 (r)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[b]인돌-3-일)아세트산 (화합물 1)의 결정성 l-아르기닌 염 |
WO2018119080A1 (fr) * | 2016-12-21 | 2018-06-28 | Cornell University | Composition et méthodes de traitement de troubles hépatiques |
WO2018151873A1 (fr) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
CA3053416A1 (fr) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Composes et methodes pour le traitement de maladies inflammatoires chroniques de l'intestin avec manifestations extra-intestinales |
CN107827837B (zh) * | 2017-11-21 | 2021-09-24 | 苏州朗科生物技术股份有限公司 | 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用 |
SG11202006255UA (en) * | 2018-02-02 | 2020-07-29 | Univ Kyoto | Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability |
EP3847158A1 (fr) | 2018-09-06 | 2021-07-14 | Arena Pharmaceuticals, Inc. | Composés utiles dans le traitement de troubles auto-immuns et inflammatoires |
CN111803636B (zh) * | 2020-07-22 | 2022-08-30 | 四川大学 | 1-磷酸鞘氨醇受体1作为microRNA-9调控血管生成的药物靶点的应用 |
RU2765464C1 (ru) * | 2021-05-20 | 2022-01-31 | Федеральное государственное бюджетное учреждение науки Институт органической химии им. Н.Д. Зеленского Российской академии наук (ИОХ РАН) | Способ получения эфиров пиперидин-4,4-дикарбоновых кислот |
JP7464075B2 (ja) | 2022-04-20 | 2024-04-09 | 株式会社大林組 | プレストレス構造及びそれを用いたプレキャストコンクリート部材 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005533058A (ja) * | 2002-06-17 | 2005-11-04 | メルク エンド カムパニー インコーポレーテッド | Edg受容体アゴニストとしての1−((5−アリール−1,2,4−オキサジアゾール−3−イル)ベンジル)アゼチジン−3−カルボキシラートおよび1−((5−アリール−1,2,4−オキサジアゾール−3−イル)ベンジル)ピロリジン−3−カルボキシラート |
WO2004035538A1 (fr) * | 2002-10-15 | 2004-04-29 | Merck & Co., Inc. | Procede de fabrication de l'acide azetidine-3-carboxylique |
JP4516430B2 (ja) * | 2002-12-20 | 2010-08-04 | メルク・シャープ・エンド・ドーム・コーポレイション | 1−(アミノ)インダン並びに(1,2−ジヒドロ−3−アミノ)−ベンゾフラン、ベンゾチオフェン及びインドール |
TW200538433A (en) * | 2004-02-24 | 2005-12-01 | Irm Llc | Immunosuppressant compounds and compositiions |
PL1650186T3 (pl) * | 2004-10-22 | 2008-11-28 | Bioprojet Soc Civ | Nowe pochodne kwasów dikarboksylowych |
-
2007
- 2007-06-15 EP EP07290748A patent/EP2014653A1/fr not_active Withdrawn
-
2008
- 2008-06-16 CN CN200880100811A patent/CN101784535A/zh active Pending
- 2008-06-16 JP JP2010511664A patent/JP5346016B2/ja not_active Expired - Fee Related
- 2008-06-16 US US12/664,718 patent/US8809539B2/en not_active Expired - Fee Related
- 2008-06-16 KR KR1020107000880A patent/KR20100040853A/ko not_active Application Discontinuation
- 2008-06-16 EA EA201000024A patent/EA018826B1/ru not_active IP Right Cessation
- 2008-06-16 MX MX2009013733A patent/MX2009013733A/es active IP Right Grant
- 2008-06-16 CA CA2693126A patent/CA2693126A1/fr not_active Abandoned
- 2008-06-16 UA UAA200912896A patent/UA99132C2/ru unknown
- 2008-06-16 WO PCT/EP2008/057571 patent/WO2008152149A1/fr active Application Filing
- 2008-06-16 BR BRPI0811712-8A2A patent/BRPI0811712A2/pt not_active IP Right Cessation
- 2008-06-16 NZ NZ581933A patent/NZ581933A/en not_active IP Right Cessation
- 2008-06-16 EP EP08761078.8A patent/EP2170850B1/fr active Active
-
2009
- 2009-12-11 ZA ZA200908851A patent/ZA200908851B/xx unknown
- 2009-12-11 TN TNP2009000524A patent/TN2009000524A1/fr unknown
- 2009-12-15 IL IL202741A patent/IL202741A0/en unknown
- 2009-12-15 MA MA32421A patent/MA31447B1/fr unknown
- 2009-12-15 CO CO09143477A patent/CO6251262A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2170850A1 (fr) | 2010-04-07 |
EA018826B1 (ru) | 2013-11-29 |
KR20100040853A (ko) | 2010-04-21 |
CO6251262A2 (es) | 2011-02-21 |
EP2170850B1 (fr) | 2014-09-24 |
TN2009000524A1 (en) | 2011-03-31 |
US8809539B2 (en) | 2014-08-19 |
JP2010529977A (ja) | 2010-09-02 |
NZ581933A (en) | 2012-01-12 |
UA99132C2 (ru) | 2012-07-25 |
MA31447B1 (fr) | 2010-06-01 |
BRPI0811712A2 (pt) | 2014-11-04 |
EP2014653A1 (fr) | 2009-01-14 |
IL202741A0 (en) | 2010-06-30 |
US20100249187A1 (en) | 2010-09-30 |
CN101784535A (zh) | 2010-07-21 |
EA201000024A1 (ru) | 2010-06-30 |
WO2008152149A1 (fr) | 2008-12-18 |
MX2009013733A (es) | 2010-04-22 |
AU2008263817A1 (en) | 2008-12-18 |
JP5346016B2 (ja) | 2013-11-20 |
CA2693126A1 (fr) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL202741A0 (en) | Novel dicarboxylic acid derivatives as s1p1 receptor agonists | |
ME02124B (fr) | Nouvelles imidazoquinolines substituées | |
HK1140761A1 (en) | Indole derivatives as s1p1 receptor agonists | |
IL192657A0 (en) | Novel thiophene derivatives as s1p1/edg1 receptor agonists | |
IL200911A0 (en) | Amino-pyridine derivatives as s1p1/edg1 receptor agonists | |
IL213630A0 (en) | Oxadiazole derivatives as slpl receptor agonists | |
HK1134294A1 (en) | Thiophene derivatives as s1p1/edg1 receptor agonists | |
ZA201103542B (en) | Novel composition based on gamma-hydroxybutric acid | |
HK1170479A1 (en) | Pyridin-4-yl derivatives as s1p1/edg1 agonists | |
IL186150A0 (en) | Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists | |
ZA200709086B (en) | Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists | |
HK1226051A1 (zh) | 14-羥基-二十二烯酸化合物 | |
IL210639A0 (en) | Oxazolopyrimidines as edg-1 receptor agonists | |
EP2223697A4 (fr) | Préparation contenant une bactérie d'acide lactique | |
EP2343292A4 (fr) | Nouveau dérivé de prostaglandine i<sb>2</sb> | |
PL2213669T3 (pl) | Krystaliczna pochodna kwasu imidazolo-5-karboksylowego | |
IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
HK1151025A1 (en) | Oxazolidine derivatives as nmda antagonists | |
ZA200903829B (en) | Indole derivatives as S1P1 receptor agonists | |
HUE038256T2 (hu) | Új helyettesített imidazokinolinok |